Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 13, 2026 01:15 ET | Source: Novartis Pharma AG

Novartis Vanrafia® Phase III data support slowing of kidney function decline in patients with IgA nephropathy

In ALIGN study, Vanrafia (atrasentan) showed positive difference in eGFR change from baseline vs. placebo at Week 136, 4 weeks after study treatment ended1Results favored Vanrafia across multiple...
February 12, 2026 08:00 ET | Source: Annovis Bio Inc.

Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer’s Disease

MALVERN, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...
February 11, 2026 04:00 ET | Source: SNS Insider pvt ltd

Hepatitis B Treatment Market Size is Projected to Reach USD 7.74 Billion by 2033 Due to the Increasing Disease Management Trends Globally

Hepatitis B Treatment Market to reach USD 7.74B by 2033, driven by rising chronic cases, antiviral innovation, and expanding global screening programs.
February 11, 2026 01:00 ET | Source: Medidata Solutions, Inc.

Medidata Delivers a Decade of AI Leadership to 500+ Clinical Studies and Growing

NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, continues to accelerate clinical trial...
February 10, 2026 04:06 ET | Source: Research and Markets

EZH2 Targeted Therapy Market Research 2026: Ipsen Leads With Tazverik, Hengrui and Pfizer Advance Next-Generation EZH2 Programs - Opportunities, Approved Drug Prices, Sales, Clinical Trials Insights

Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "EZH2 Targeted Therapy Market Opportunity, Approved Drug Price, Sales and Clinical Trials Insight 2026" report has been added to ...
February 10, 2026 04:05 ET | Source: Research and Markets

Claudin 18.2 Targeted Therapy Market Research 2026: Astellas' Zolbetuximab Leads Gastric Cancer Progress, While Servier Pharmaceuticals and Others Expand ADC and CAR-T Strategies - Forecasts to 2030

Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "Claudin 18.2 Targeted Therapy Market Opportunity, Therapeutic Approaches, Approved Drug Price, Sales and Clinical Trials Insight 2030" report has been...
February 05, 2026 07:18 ET | Source: Research and Markets

Crohn's Disease (Regional Enteritis) Global Clinical Trials Market Review 2025: G7 and E7 Activities, Trial Status, Sponsor Insights, Enrollment Trends, Company Listings, Unaccomplished Trials

Dublin, Feb. 05, 2026 (GLOBE NEWSWIRE) -- The "Crohn's Disease (Regional Enteritis) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This...
February 05, 2026 07:17 ET | Source: Research and Markets

Bronchiectasis Global Clinical Trials Market Review 2025: G7 and E7 Activities, Trial Status, Sponsor Insights, Enrollment Trends, Company Listings, Unaccomplished Trials

Dublin, Feb. 05, 2026 (GLOBE NEWSWIRE) -- The "Bronchiectasis - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides top...
February 05, 2026 07:15 ET | Source: Research and Markets

Cutaneous Squamous Cell Carcinoma (cSCC) Global Clinical Trials Market Review 2025: G7 and E7 Activities, Trial Status, Sponsor Insights, Enrollment Trends, Company Listings, Unaccomplished Trials

Dublin, Feb. 05, 2026 (GLOBE NEWSWIRE) -- The "Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's...
February 05, 2026 07:14 ET | Source: Research and Markets

Phenylketonuria (PKU) Global Clinical Trials Market Review 2025: G7 and E7 Activities, Trial Status, Sponsor Insights, Enrollment Trends, Company Listings, Unaccomplished Trials

Dublin, Feb. 05, 2026 (GLOBE NEWSWIRE) -- The "Phenylketonuria (PKU) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...